Skip to main content

Brian Caveney

Brian Caveney will join Laboratory Corporation of America as enterprise-wide chief medical officer on Sept. 25. He will report to LabCorp Chairman and CEO David King. In the newly created role, Caveney will oversee LabCorp’s medical and scientific strategy, and serve as the company’s primary external medical representative, defining global standards for medical and scientific activities across LabCorp’s diagnostic and drug development businesses. Caveney is currently chief medical officer of Blue Cross and Blue Shield of North Carolina. 

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.